Neo Ivy Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-896
| Closed | -$188K | – | 345 |
|
|
2025
Q1 | $188K | Buy |
+896
| New | +$188K | 0.06% | 222 |
|
|
2023
Q3 | – | Sell |
-894
| Closed | -$120K | – | 308 |
|
|
2023
Q2 | $120K | Buy |
+894
| New | +$120K | 0.06% | 231 |
|
|
2022
Q4 | – | Sell |
-1,174
| Closed | -$158K | – | 313 |
|
|
2022
Q3 | $158K | Buy |
+1,174
| New | +$158K | 0.42% | 93 |
|
|
2022
Q2 | – | Sell |
-546
| Closed | -$88K | – | 383 |
|
|
2022
Q1 | $88K | Buy |
+546
| New | +$88K | 0.08% | 317 |
|
|
2021
Q3 | – | Sell |
-2,222
| Closed | -$250K | – | 439 |
|
|
2021
Q2 | $250K | Sell |
2,222
-1,480
| -40% | -$167K | 0.25% | 149 |
|
|
2021
Q1 | $401K | Buy |
+3,702
| New | +$401K | 0.44% | 69 |
|
|
2020
Q4 | – | Sell |
-4,514
| Closed | -$395K | – | 400 |
|
|
2020
Q3 | $395K | Buy |
+4,514
| New | +$395K | 0.4% | 79 |
|
|
2020
Q2 | – | Sell |
-3,253
| Closed | -$248K | – | 440 |
|
|
2020
Q1 | $248K | Sell |
3,253
-421
| -11% | -$32.1K | 0.4% | 82 |
|
|
2019
Q4 | $325K | Buy |
+3,674
| New | +$325K | 0.38% | 120 |
|
|
2019
Q3 | – | Sell |
-3,214
| Closed | -$234K | – | 273 |
|
|
2019
Q2 | $234K | Sell |
3,214
-7,155
| -69% | -$521K | 0.13% | 197 |
|
|
2019
Q1 | $835K | Buy |
+10,369
| New | +$835K | 0.47% | 95 |
|